Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor‐experienced patients with hepatitis C: Real‐world data from a multicenter Asian registry

Detalles Bibliográficos
Autores principales: Wong, YJ, Kumar, R, Tan, J, Liu, CH, Hui, VW‐K, Tan, SS, Kao, JH, Wong, GL‐H, Thurairajah, PH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543910/
https://www.ncbi.nlm.nih.gov/pubmed/35723645
http://dx.doi.org/10.1111/jgh.15918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543910/
https://www.ncbi.nlm.nih.gov/pubmed/35723645
http://dx.doi.org/10.1111/jgh.15918

Ejemplares similares